Transcription of Genetic Testing – Medicare Advantage Coverage Summary
{{id}} {{{paragraph}}}
Page 1 of 23 UHC MA Coverage Summary : Genetic Testing Proprietary Information of UnitedHealthcare. Copyright 2020 United HealthCare Services, Inc. Coverage Summary Genetic Testing Policy Number: G-003 Products: UnitedHealthcare Medicare Advantage Plans Original Approval Date: 02/14/2008 Approved by: UnitedHealthcare Medicare Benefit Interpretation Committee Last Review Date: 08/18/2020 Related Medicare Advantage Policy Guidelines: BRCA1 and BRCA2 Genetic Testing Cytogenic Studies ( ) Genetic Testing for Lynch Syndrome Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) Typing Molecular Pathology/ Genetic Testing Reported with Unlisted Codes Molecular Pathology/Molecular Diagnostics/ Genetic Testing Tier 2 Molecular Pathology Procedures This information is being distributed to you for personal reference. The information belongs to UnitedHealthcare and unauthorized copying, use, and distribution are prohibited.
Prostate Specific Antigen (190.31) Alpha-fetoprotein (190.25) ... Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions. Note: After checking the . ... technique that can measure one or more genetic variations as a laboratory diagnostic test, such as when used as a companion ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}